Market's view on Tristel
Published on April 2024
- Tristel has licensed its chlorine dioxide chemistry to Clorox, which was viewed as a strategic move to block Tristel’s entry into the US market.
- A significant distributor agreement has been signed between HeiQ’s Life Sciences Business Unit and Ecolab Inc. for the supply of HeiQ Synbio Cleaners.
- Concerns were raised about Tristel potentially acquiring Byotrol, with opinions divided on whether it would be beneficial or detrimental to Tristel.
- Tristel has entered into a know-how license and product supply agreement with Byotrol plc. This includes the joint development of a biocidal formulation and two additional biocidal products, which Tristel will incorporate into its hospital disinfectant products.
- There is skepticism about the speed of healthcare adoption of new technologies, which could affect the success of the newly developed products despite their innovative properties.